Browse Solutions: Enterprise Management
- White Papers/Case Studies (170)
- Analyst Reports (1)
- Webcasts (0)
- Multimedia (0)
FEATURED REPORTS
WHAT'S NEW
-
PAT and TOC Analysis With an Onboard Automated Standards Introduction System ...
by Hach Ultra
White paper
<P>This paper describes the use of an on-board automated sample introduction system (OASIS) that is used to run verification standards and system suitability tests in order to ensure the reliability of the TOC results. </P>
-
Comparison of TOC Analyzers and Sensors for Pharmaceutical TOC Applications
by GE Analytical Instruments
Application note
In 2006, Jon S. Kauffman, PhD., Lancaster Laboratories, published results from a study on the recovery of organic compounds likely to be present in pharmaceutical water systems using on-line TOC analyzers designed for pharmaceutical use. A new study repeats the same injections, but adds the new CheckPoint TOC Sensor from GE Analytical Instruments.
REPORTS BY TOPIC
Sarbanes-Oxley: Beyond planning
By Clarkston Consulting
White paper
In 2003, Clarkston Consulting conducted a survey of ten companies on the topics of Sarbanes-Oxley planning and remediation, aimed at chief information officers (CIOs) and their roles in planning and ensuring compliance.
Operational Effectiveness: ERP Strategies for Emerging Life Science Companies
By Ross Systems Inc.
White paper
Scientific discovery is the fuel that drives the Life Sciences sector, including Biotechnology, Pharmaceutical, Diagnostics and Medical Device companies. Life Science companies must meet enormous challenges as they commercialize new discoveries.
There are currently no reports available for this topic.
Price trends for frequently used brand and generic drugs, 2000-2004
By U.S. Government Accountability Office
White paper
This U.S. Government Accountability Office white paper tracked average prices charged at retail pharmacies for drugs. Its conclusion? Prescription drug spending has been the fastest-growing segment of national health expenditures.
What patent owners should consider in filing for a patent term extension
By Sterne Kessler Goldstein & Fox PLLC
White paper
This white paper by Sterne Kessler Goldstein & Fox PLLC discusses four essential points that manufacturers must be aware of with the Hatch-Waxman Act, which clarified patent extension law.
Fighting generic competition: Strategies for research-based companies
By URCH Publishing
White paper
This white paper from URCH Publishing Ltd. discusses the pros and cons of litigation and other approaches by pharma companies to protect their patent exclusivity and intellectual property in the face of patent expirations.
Content management streamlines government compliance for pharmaceutical company
By EMC Corp.
Case study
In this case study, EMC Corp.’s content management system streamlines the submission of new drug applications, supports documentation and cuts time to market for approved drugs for Otsuka America Pharmaceutical Co.
Managing strategic assets and speeding time to market
By EMC Corp.
Case study
In this case study, EMC Corp. helps Purdue Pharma LP streamline the production and exchange of content related to regulatory submission processes, connect disparate information systems and move information between those systems.
Market size in innovation: Theory and evidence from the pharmaceutical industry
By Massachusetts Institute of Technology
White paper
This white paper by MIT develops a simple model linking innovation to potential market size, and shows that under a variety of circumstances, greater market size for a particular product, which implies greater sales, spurs faster innovation.
Reaching the Full Potential of Lean Quality
White paper
This white paper by IQS discusses lean quality initiatives and Enterprise Quality and Compliance Management software.
Creating a Six Sigma culture
By CLG
White paper
How do you help people embrace Six Sigma? According to this white paper from CLG, the key is to treat your efforts as a cultural change within your organization.
Adapting lean manufacturing for a high-mix environment using flow path ...
By Invistics Corp.
White paper
This white paper by Invistics Corp. describes how to improve manufacturing performance in a high-mix environment using lean manufacturing techniques via flow path management.
Black belt not required: Don't wait for Six Sigma to come to you
By Johnson & Johnson Pharmaceutical Research & Development LLC
White paper
Six Sigma is more than a tool or technique for pharmaceutical companies, according to this white paper from Johnson & Johnson Pharmaceuticals Group: It has to be the way you do business.
Lean principles: Integrated business processes or "random acts of Lean?"
By Aberdeen Group
White paper
The Aberdeen Group reports on many manufacturers, distributors, and service providers who perform random acts of Lean but still struggle with cash.
Scaling up production: The Achilles heel of many manufacturers
By Clarkston Consulting
White paper
Many manufacturers sustain huge economic losses from inefficient scale-up of R&D to full-scale manufacturing. According to this white paper by Clarkston Consulting, performing design for manufacturability, failure mode analysis and failure mode and effect analysis on the development of new products can reduce these losses.
Cracking Japanese drug development: A view from the inside
By Fulcrum Pharma Developments
White paper
This white paper from Fulcrum Pharma Developments Inc. features an interview with Teruyoshi Okuda, president of Fulcrum Pharma Developments KK. The Japanese market has always been difficult to access from the West due to differences in culture, medical approaches and regulatory requirements, but by choosing the right people on the ground, Western companies can succeed.
The program management office
By Clarkston Consulting
White paper
This white paper from Clarkston Consulting explains how a program management office can support business objectives to deliver better products and services at lower prices, improve visibility into the sales pipeline, integrate systems and provide real-time reports.
Scorecards and dashboards: More than just technology
By Clarkston Consulting
White paper
Before implementing a scorecard or dashboard application, according to this white paper from Clarkston Consulting, executives should consider what information or metrics they require to provide the right focus on organization, success and business value.
HealthCast tactics: A blueprint for the future
By PricewaterhouseCoopers
White paper
For this 2002 report by PricewaterhouseCoopers, more than 65 health care thought leaders were interviewed. The survey found significant gaps in providers reporting quality and safety data, payers reducing unnecessary administrative costs, and understanding how patient data is shared.
Mea culpa by a big pharma CEO
By Pfizer Inc.
White paper
Dr. Peter Rost, vice president of marketing for Pfizer Inc., reviews A Call to Action, a book by his boss, Pfizer CEO Hank McKinnell, about the pharmaceutical industry.
Pressure points: Risk management in the pharmaceuticals industry
By KPMG International
White paper
This white paper from KPMG puts forward ideas on how risk management can be improved in the pharmaceutical industry during a time of change and evolution.
Cerity ECM—protecting intellectual property
By Agilent Technologies
Application note
In this application note, Agilent Technologies describes how to protect intellectual property using its Cerity ECM (enterprise content management).
Contingency Planning for Biopharma Manufacturing
White paper
<P>In order to survive a disaster or other business shut down, biotechnology companies need to combine their insurance portfolio with an effective disaster-recovery plan that will serve as a road map, providing directions the company will take if a catastrophe or other business interruption strikes.</P>
Risk Management in Next Generation Outsourcing
White paper
In the white paper, law firm Hunton & Williams and leading insurance broker Marsh examine how new outsourcing models have resulted in new areas of risk and a more complex contractual and commercial structure being required.
Prescriptions for the smart and lean pharmaceutical company
By Capgemini
White paper
This 2003 Cap Gemini Ernst & Young/INSEAD survey provides a snapshot of the customer perspective on health care and examines how these customer needs will affect the relationship between pharmaceutical companies and their customers.
Ten ways to drive performance
By Cognos Inc.
White paper
Cognos Inc. presents practical ways companies can begin corporate performance management (CPM) with alignment in their sales and marketing departments, two areas that have a significant impact on the bottom line.
Solvay Pharmaceuticals Inc. upgrades mobile workforce technology
By Dell Inc.
Case study
In this case study, Dell Services helps Solvay Pharmaceuticals Inc., a research-based pharma company, develop a mobile solution to manage its 1,000 remote field employees. It overcame delivery and deployment hurdles, provided effective asset management tools and offered financing options efficiently.
Customer intelligence management benchmark report
By Aberdeen Group
White paper
According to this 2005 white paper from Aberdeen Group, companies exemplifying best-in-class customer intelligence management practices reported greater than 25 percent improvement in revenues and customer acquisition and retention rates.
Enabling pharmaceutical sales support to increase productivity and ...
By Dendrite International
White paper
According to this white paper by Dendrite International Inc., more than 70 percent of requests placed by pharmaceutical sales reps to a help desk relate to sales and marketing services. Pharmaceutical companies should view the help desk as support that can increase sales productivity and effectiveness.
Alternative sales channel expands physician coverage at lower cost
By ICT Group
Case study
In this case study, ICT Group helps a pharmaceutical company spread the word about a new treatment for an under-diagnosed condition in men by using its Direct Response Medical Detailing program.
Governance: An essential component for successful outsourcing
By Hogan & Hartson LLP
White paper
Hogan & Hartson LLP outline the importance of governance in successful outsourcing, including clear management of communications, performance, change and disputes.
The future of the life sciences industry
By Deloitte & Touche USA
White paper
This survey of life sciences executives conducted by the Economist Intelligence Unit and Deloitte Touche Tohmatsu found that growing pressure will help speed up industrial consolidation and convergence in the pharmaceutical industry.
Ask Japan where innovation begins
By Mitsubishi Corp.
White paper
This white paper by Mitsubishi Corp. profiles Japan's pharmaceutical and biotechnology sectors, which are second- and fifth-largest in the world, respectively.
The role of foreign-born and U.S. immigration policies in science and ...
By American Immigration Law Foundation
White paper
In this white paper by the American Immigration Law Foundation's Immigration Policy Center, the role of immigrant scientists and engineers within the U.S. economy is studied, and the impact of immigration restrictions on U.S. technology development discussed.
Orbital Welding Training for Maximum Results
By Swagelok Co.
Product collateral
The four-day course offered by Swagelok Co. consists of a series of lectures and hands-on activities to develop an understanding of welding principles.
Aggressive biotechs succeed: Selecting the right pharmaceutical partner
By Vantage Partners
White paper
In this white paper, Vantage Partners LLC discusses how biotechs can select the right pharmaceutical partners and establish appropriate terms and expectations with them.
Where are the academics?
By RFID Alliance Lab, University of Kansas
White paper
Industry needs the objectivity of academia to promote radio frequency identification (RFID) technology, according to this white paper from the RFID Alliance Lab at the University of Kansas.
Focus on innovation
By Pharmaceutical Research and Manufacturers of America (PhRMA)
White paper
This white paper by Pharmaceutical Research and Manufacturers of America (PhRMA) is primarily a statistical profile of the U.S. pharma industry in 2004.
The Path to Strategic Flexibility
By 2Value Consulting Group Inc.
White paper
In this white paper, 2Value Inc. explores how biopharma execs can use advanced financial evaluation and decision analysis techniques such as real options analysis to value and structure strategic investments.
Aggressive biotechs succeed: Selecting the right pharmaceutical partner
By Vantage Partners
White paper
This white paper by Vantage Partners LLC discusses how biotechs interested in growing can select the right partners through strategic, operational and relationship assessments, and establish appropriate terms and expectations.
The Impact of Nanotechnology in Drug Delivery: Global Developments, Market ...
White paper
This report will include an overview of nanoenabled drug delivery technologies, commercial applications and information on the companies pursuing them, information on nanotechnology initiatives and regulation in major international markets (North America, EU, Japan, Israel, etc.), as well as eight-year worldwide forecasts on the industry’s anticipated growth and timing thereof.
